Current status and perspective of liver preservation solutions

Hepatobiliary and Pancreatic Diseases International

Volumn 5, Issue 4, 2006, Pages 490-494

  Feng, Xiao Ning ^a   Xu, Xiao ^a   Zheng, Shu Sen ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Biliary complication; Liver preservation solution; Microcirculation; Protective gene

Indexed keywords

CELSIOR; FRUCTOSE 1,6 BISPHOSPHATE; HTK SOLUTION; INSULIN; PRESERVATION SOLUTION; PROTEIN BCL 2; PROTEIN BCL XL; TSUKUBAENOLIDE; TUMOR NECROSIS FACTOR ALPHA; UNIVERSITY OF WISCONSIN SOLUTION;

BILE DUCT OBSTRUCTION; BILIARY TRACT DISEASE; GRAFT SURVIVAL; HUMAN; INCIDENCE; ISCHEMIA; LIVER FAILURE; LIVER PRESERVATION; LIVER PROTECTION; LIVER TRANSPLANTATION; MEDLINE; MICROCIRCULATION; NONHUMAN; ORGAN DONOR; RESOURCE ALLOCATION; REVIEW; SYSTEMATIC REVIEW; VISCOSITY;

ADENOSINE; ALLOPURINOL; ANIMALS; ANTIBODIES; BILE DUCT DISEASES; DISACCHARIDES; ELECTROLYTES; FRUCTOSEDIPHOSPHATES; GLUCOSE; GLUTAMATES; GLUTATHIONE; HISTIDINE; HUMANS; INSULIN; ISCHEMIA; LIVER; MANNITOL; MICROCIRCULATION; ORGAN PRESERVATION SOLUTIONS; POTASSIUM CHLORIDE; PROCAINE; RAFFINOSE; TACROLIMUS; TRANSFORMATION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33751234481     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. St Peter SD, Imber CJ, Friend PJ. Liver and kidney preservation by perfusion. The Lancet 2002;359:604-613.
2. Ben-Ari Z, Hochhauser E, Burstein I, Papo O, Kaganovsky E, Krasnov T, et al. Role of anti-tumor necrosis factor-alpha in ischemia/reperfusion injury in isolated rat liver in a blood-free environment. Transplantation 2002;73:1875-1880.
3. Li S, Stratta R, Langnas A, Wood R, Marujo W, Shaw BJ. Diffuse biliary tract injury after orthotopic liver transplantation. Am J Surg 1992;164;536-540.
4. He XS, Ma Y, Ju WQ, Wu LW, Wu JL, Liang YJ, et al. Dynamic microcirculatory changes in liver graft from non-heart-beating donor with warm ischemia injury in rat. Hepatobiliary Pancreat Dis Int 2004;3:179-182.
5. van der Plaats A, Hart NA, Morariu AM. Effect of University of Wisconsin organ-preservation solution on haemorheology. Transpl Int 2004;17:227-233.
6. Hauet T, Baumert H, Amor IB, Goujon JM, Gibelin H, Godart C, et al. Protection of autotransplanted pig kidneys from ischemia-reperfusion injury by polyethylene glycol. Transplantation 2000;70:1569-1575.
7. Pokorny H, Rasoul-Rockenschaub S, Langer F, Windhager T, Rosenstingl A, Lange R, et al. Histidine-tryptophan-ketoglutarate solution for organ preservation in human liver transplantation - a prospective multi-centre observation study. Transpl Int 2004;17:256-260.
8. Mangus RS, Tector AJ, Agarwal A, Vianna R, Murdock P, Fridell JA. Comparison of histidine-tryptophan-ketoglutarate solution (HTK) and University of Wisconsin solution (UW) in adult liver transplantation. Liver Transpl 2006;12:226-230.
9. Testa G, Malago M, Nadalin S. Histidine-tryptophan-ketoglutarate versus University of Wisconsin solution in living donor liver transplantation: results of a prospective study. Liver Transpl 2003;9:822-826.
10. Garcia-Criado FJ, Palma-Vargas JM, Valdunciel-Garcia JJ, Toledo AH, Misawa K, Gomez-Alonso A, et al. Tacrolimus(FK506) down-regulates free radical tissue levels, serum cytokines, and neutrophil infiltration after severe liver ischemia. Transplantation 1997;64:594-598.
11. Meneu Diaz JC, Vicente E, Nuno J, Quijano Y, Lopez-Hervas P, Barcena R, et al. Prospective comparative study of the efficacy of celsior solution for preservation in clinical liver transplant. Transplant Proc 2002;34:49.
12. Ohwada S, Sunose Y, Tsutsumi H, Iwazaki S, Aiba M, Kasahara M, et al. Celsior is superior to UW for graft preservation from non-heart-beating donors in a canine liver transplantation model. Transplant Proc 2001;33:922-923.
13. Nardo B, Beltempo P, Bertelli R, Montalti R, Vivarelli M, Urbani L, et al. Comparison of Celsior and University of Wisconsin solutions in cold preservation of liver from octogenarian donors. Transplant Proc 2004;36:523-524.
14. Spiegel HU, Schleimer K, Freise H, Diller R, Drews G, Kranz D. Organ preservation with EC, HTK, and UW solution in orthotopic rat liver transplantation. J Invest Surg 1999;12: 195-203.
15. Pirenne J, Van Gelder F, Coosemans W, Aerts R, Gunson B, Koshiba T, et al. Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation. Liver Transpl 2001;7:540-545.
16. Erhard J, Lange R, Scherer R, Kox WJ, Bretschneider HJ, Gebhard MM, et al. Comparison of HTK solution versus UW solution for organ preservation in human liver transplantation. Transpl Int 1994;7:177-181.
17. Lama C, Rafecas A, Figueras J, Torras J, Ramos E, Fabregat J, et al. Comparative study of celsior and belzer solutions for hepatic graft preservation: preliminary results. Transplant Proc 2002;34:54-55.
18. Cameron AM, Busuttil RW. Ischemic cholangiopathy after liver transplantation. Hepatobiliary Pancreat Dis Int 2005; 4:495-501.
19. Xu WH, Ye QF, Xia SS. Apoptosis and proliferation of intrahepatic bile duct after ischemia-reperfusion injury. Hepatobiliary Pancreat Dis Int 2004;3:428-432.
20. Langrehr J, Schneller A, Neuhaus R, Vogl T, Hintze R, Neuhaus P. Etiologic factors and incidence of ischemic type biliary lesions (ITBL) after liver transplantation. Arch Surg 1998;115:S1560-S1562.
21. Cascales P, Fernandez V, Tomas A, Sanchez del Campo F, Gonzalez F, Tascon E, et al. Comparison of UW and celsior solutions in experimental liver preservation by assessment of alpha-glutathione sulfotransferase. Transplant Proc 2002;34:53.
22. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl 2003;9:651-663.
23. Chmiel B, Cierpka L. Organ preservation solutions impair deformability of erythrocytes in vitro. Transplant Proc 2003;35:2163-2164.
24. Xu X, Man K, Zheng SS, Liang TB, Lee TK, Ng KT, et al. Attenuation of acute phase shear stress by somatostatin improves small-for-size liver graft survival. Liver Transpl 2006;12:621-627.
25. Xiao JS, Cai FG, Niu Y, Zhang Y, Xu XL, Ye QF. Preconditioning effects on expression of proto-oncogenes c-fos and c-jun after hepatic ischemia/ reperfusion in rats. Hepatobiliary Pancreat Dis Int 2005;4:197-202.
26. Woodside KJ, Song J, Song W, Hu M, Meng T, Hunter GC, et al. Immunomodulation of hepatic ischemic injury via increased bcl-X(L) and decreased bcl-X(S). J Surg Res 2003;112:59-64.
27. Ke B, Shen XD, Lassman CR, Gao F, Busuttil RW, Kupiec-Weglinski JW. Cytoprotective and antiapoptotic effects of IL-13 in hepatic cold ischemia/reperfusion injury are heme oxygenase-1 dependent. Am J Transplant 2003;3:1076-1082.
28. Lu QP, Cao TJ, Zhang ZY, Liu W. Multiple gene differential expression patterns in human ischemic liver: safe limit of warm ischemic time. World J Gastroenterol 2004;10:2130-2133.
29. Kienle K, Rentsch M, Muller T, Engelhard N, Vogel M, Jauch KW, et al. Expression of BCL-2 in liver grafts after adenoviral transfer improves survival following prolonged ischemia and reperfusion in rat liver transplantation. Transplant Proc 2005;37:439-441.
30. Scott JR, Gray DK, Bihari A, Badhwar A, Zhang X, Shan P, et al. Heme oxygenase modulates small intestine leukocyte adhesion following hindlimb ischemia/reperfusion by regulating the expression of intercellular adhesion molecule-1. Cirt Care Med 2005;33 :2563-2570.
31. Li XL, Man K, Ng KT, Sun CK, Lo CM, Fan ST. The influence of phosphatidylinositol 3-kinase/Akt pathway on the ischemic injury during rat liver graft preservation. Am J Transplant 2005;5:1264-1275.
32. Hirokawa F, Nakai T, Yamaue H. Storage solution containing fructose-1, 6- bisphosphate inhibits the excess activation of Kupffer cells in cold liver preservation. Transplantation 2002;74:779-781.
33. Sano W, Watanabe F, Tamai H, Furuya E, Mino M. Beneficial effect of fructose-1, 6-bisphosphate on mitochondrial function during ischemia-reperfusion of rat liver. Gastroenterology 1995;108:1785-1792.
34. Moresco RN, Santos RC, Alves Filho JC, Cunha AA, Dos Reis C, Reichel CL, et al. Protective effect of fructose-1, 6-bisphosphate in the cold storage solution for liver preservation in rat hepatic transplantation. Transplant Proc 2004;36:1261-1264.
35. Li XL, Man K, Liu YF. Insulin in University of Wisconsin solution exacerbates the ischemic injury and decreases the graft survival rate in rat liver transplantation. Transplantation 2003;76:44-49.
36. Moore DE, Feurer ID, Speroff T, Gorden DL, Wright JK, Chari RS, et al. Impact of donor, technical, and recipient risk factors on survival and quality of life after liver transplantation. Arch Surg 2005;140:273-277.